Evidence map›Paper›PMID 36365510›Full record

ArticlePolymers2022

Effect of Cellulose Nanofibers' Structure and Incorporation Route in Waterborne Polyurethane-Urea Based Nanocomposite Inks.

Izaskun Larraza, Julen Vadillo, Tamara Calvo-Correas, Alvaro Tejado, Loli Martin, Aitor Arbelaiz, Arantxa Eceiza

Abstract read
In one paragraph

Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Izaskun LarrazaMaterials + Technologies' Research Group (GMT), Department of Chemical and Environmental Engineering, Faculty of Engineering of Gipuzkoa, University of the Basque Country, Pza Europa 1, 20018 Donostia-San Sebastian, Spain.
Julen VadilloMaterials + Technologies' Research Group (GMT), Department of Chemical and Environmental Engineering, Faculty of Engineering of Gipuzkoa, University of the Basque Country, Pza Europa 1, 20018 Donostia-San Sebastian, Spain.ORCID 0000-0002-5455-4805
Tamara Calvo-CorreasMaterials + Technologies' Research Group (GMT), Department of Chemical and Environmental Engineering, Faculty of Engineering of Gipuzkoa, University of the Basque Country, Pza Europa 1, 20018 Donostia-San Sebastian, Spain.ORCID 0000-0002-1616-9252
Alvaro TejadoTECNALIA, Basque Research and Technology Alliance (BRTA), Area Anardi 5, 20730 Azpeitia, Spain.ORCID 0000-0001-6261-1948
Loli MartinMacrobehavior-Mesostructure-Nanotechnology, General Research Service (SGIker), Polytechnic School, University of the Basque Country, Plaza Europa 1, 20018 Donostia-San Sebastián, Spain.ORCID 0000-0003-3756-4582
Aitor ArbelaizMaterials + Technologies' Research Group (GMT), Department of Chemical and Environmental Engineering, Faculty of Engineering of Gipuzkoa, University of the Basque Country, Pza Europa 1, 20018 Donostia-San Sebastian, Spain.
Arantxa EceizaMaterials + Technologies' Research Group (GMT), Department of Chemical and Environmental Engineering, Faculty of Engineering of Gipuzkoa, University of the Basque Country, Pza Europa 1, 20018 Donostia-San Sebastian, Spain.ORCID 0000-0001-6471-9215

Funding

Basque Government Elkartek KK19-00048Basque Government Grupos Consolidados (IT-1690-22)
6 · The paper itself

Abstract

In order to continue the development of inks valid for cold extrusion 3D printing, waterborne, polyurethane-urea (WBPUU) based inks with cellulose nanofibers (CNF), as a rheological modulator, were prepared by two incorporation methods,

Indexed as

3D printingbioinkscellulose nanofiberscold extrusionwaterborne polyurethane–urea

Identifiers

PMID36365510
PMCPMC9654412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.